[Ambulatory chemotherapy of hematosarcoma].
The results of outpatient polychemotherapy of 102 out of 120 patients with hematosarcoma are discussed. The outpatient treatment of hematosarcoma was found as effective as in hospital. The best results were registered in application of VAMP (vincristine, methotrexate, 6-mercaptopurine and prednisolone) and COP (cyclophosphamide, vincristine or oncovin and prednisolone) schemes--complete remission was observed in 50.0 and 32.9% of cases, respectively. Outpatient chemotherapy of hematosarcoma offers advantages since it may be given to larger numbers of patients. Side-effects and complication of chemotherapy appeared to be slight and unstable.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000505:Alopecia / Q000139:chemically induced; D000553:Ambulatory Care; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D013280:Stomatitis / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
Ambulatornaia khimioterapiia gematosarkom.